Quantitative PCR-based approach for rapid phage display analysis: a foundation for high throughput vascular proteomic profiling
Open Access
- 1 August 2006
- journal article
- research article
- Published by American Physiological Society in Physiological Genomics
- Vol. 26 (3), 202-208
- https://doi.org/10.1152/physiolgenomics.00025.2006
Abstract
Functional proteomic strategies offer unique advantages over current molecular array approaches, as the epitopes identified can directly provide bioactive peptides for investigational and/or translational applications. The vascular endothelium is well suited to proteomic assessment by in vivo phage display, but extensive enrichment and sequencing steps limit its application for high throughput molecular profiling. To overcome these limitations we developed a quantitative PCR (Q-PCR) strategy to allow the rapid quantification of in vivo phage binding. Primers were designed for distinct clones selected from a defined phage pool to probe for age-associated changes in cardiac vascular epitopes. Sensitivity and specificity of the primer sets were tested and confirmed in vitro. Q-PCR quantification of phage in vivo confirmed the preferential homing of all phage clones to the young rather than old cardiac vasculature and demonstrated a close correlation with phage measurements previously determined using traditional bacterial-based titration methods. This Q-PCR approach provides quantification of phage within hours of phage injection and may therefore be used for rapid, high throughput analysis of binding of defined phage sequences both in vivo and in vitro, complementing nonbiased phage approaches for the proteomic mapping of vascular beds and other tissues.Keywords
This publication has 24 references indexed in Scilit:
- Synchronous selection of homing peptides for multiple tissues byin vivophage displayThe FASEB Journal, 2006
- BDNF-mediated enhancement of inflammation and injury in the aging heartPhysiological Genomics, 2006
- Vascular tenascin‐C regulates cardiac endothelial phenotype and neovascularizationThe FASEB Journal, 2006
- Spatial and temporal dynamics of the endotheliumJournal of Thrombosis and Haemostasis, 2005
- Inhibition of the angiogenesis by the MCP‐1 (monocyte chemoattractant protein‐1) binding peptideFEBS Letters, 2005
- Antibody phage display technologies with special reference to angiogenesisThe FASEB Journal, 2004
- In vitro Selection of a Peptide with High Selectivity for Cardiomyocytes In vivoJournal of Molecular Biology, 2004
- Integrin αIIbβ3 specific synthetic human monoclonal antibodies and HCDR3 peptides that potently inhibit platelet aggregationThe FASEB Journal, 2003
- Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cellsThe FASEB Journal, 2002
- Searching for Peptide Ligands with an Epitope LibraryScience, 1990